Evidence map›Paper›PMID 31781832›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Influence of the scan time point when assessing hypoxia in

Kentaro Kobayashi, Osamu Manabe, Kenji Hirata, Shigeru Yamaguchi, Hiroyuki Kobayashi, Shunsuke Terasaka, Takuya Toyonaga, Sho Furuya, Keiichi Magota, Yuji Kuge and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Potential novel imaging targets of inflammation in cardiac sarcoidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kentaro KobayashiDepartment of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Hokkaido, 060-8638, Japan.
Osamu ManabeDepartment of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Hokkaido, 060-8638, Japan.
Kenji HirataDepartment of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Hokkaido, 060-8638, Japan. khirata@med.hokudai.ac.jp.ORCID 0000-0003-0036-8975
Shigeru YamaguchiDepartment of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Hiroyuki KobayashiKashiwaba Neurosurgery Hospital, Sapporo, Japan.
Shunsuke TerasakaKashiwaba Neurosurgery Hospital, Sapporo, Japan.
Takuya ToyonagaDepartment of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Sho FuruyaDepartment of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Hokkaido, 060-8638, Japan.
Keiichi MagotaDivision of Medical Imaging and Technology, Hokkaido University Hospital, Sapporo, Japan.
Yuji KugeCentral Institute of Isotope Science, Hokkaido University, Sapporo, Japan.
Kohsuke KudoDepartment of Diagnostic Imaging, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Tohru ShigaDepartment of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Hokkaido, 060-8638, Japan.
Nagara TamakiDepartment of Radiology, Kyoto Prefectural University, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose

methodsTwenty-three patients with or suspected of having a brain tumor were scanned twice at 2 and 4 h following an intravenous injection of

resultsAt 2 h, the SUVmean of gray matter was significantly higher than that of white matter (median 1.23, interquartile range (IQR) 1.10-1.32 vs. 1.04, IQR 0.95-1.16, p < 0.0001), whereas at 4 h, it significantly decreased to approach that of the white matter (1.10, IQR 1.00-1.23 vs. 1.02, IQR 0.93-1.13, p = NS). The gray-to-white matter ratio thus significantly declined from 1.17 (IQR 1.14-1.19) to 1.09 (IQR 1.07-1.10) (p < 0.0001). All 7 patients with glioblastoma showed significant increases in the SUVmax (2.20, IQR 1.67-3.32 at 2 h vs. 2.65, IQR 1.74-4.41 at 4 h, p = 0.016) and the TNR (1.75, IQR 1.40-2.38 at 2 h vs. 2.34, IQR 1.67-3.60 at 4 h, p = 0.016).

conclusionIn the assessment of hypoxic tumors,

Indexed as

GlioblastomaMisonidazoleHumansHypoxiaPositron-Emission TomographyRadiopharmaceuticalsfluoromisonidazoleMisonidazoleRadiopharmaceuticalsFluoromisonidazoleGlioblastomaHypoxiaPositron emission tomographyScan timingThis article is part of the Topical Collection on Oncology – Brain

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.